Author:
Lacouture Mario E.,Maitland Michael L.,Segaert Siegfried,Setser Ann,Baran Robert,Fox Lindy P.,Epstein Joel B.,Barasch Andrei,Einhorn Lawrence,Wagner Lynne,West Dennis P.,Rapoport Bernardo L.,Kris Mark G.,Basch Ethan,Eaby Beth,Kurtin Sandra,Olsen Elise A.,Chen Alice,Dancey Janet E.,Trotti Andy
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. CTC v2.0 and common terminology criteria for adverse events v3.0 (CTCAE). Available at http://ctep.cancer.gov/reporting/index.html . Accessed on 4 Mar 2008. CTCAE v4.0 available on May 28, 2009 at https://cabig-kc.nci.nih.gov/Vocab/KC/index.php/CTCAE
2. Edgerly M, Fojo T (2008) Is there room for improvement in adverse event reporting in the era of targeted therapies? J Natl Cancer Inst 100(4):240–242
3. Roé E, García Muret MP, Marcuello E, Capdevila J, Pallarés C, Alomar A (2006) Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients. J Am Acad Dermatol 55(3):429–437
4. Wagner LI, Lacouture ME (2007) Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist’s perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae. Oncology 21:34–36
5. Boone SL, Rademaker A, Liu D, Pfeiffer C, Mauro DJ, Lacouture ME (2007) Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results. Oncology 72(3–4):152–159
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献